Home » Posts tagged with » United Kingdom
Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and identify viruses within five minutes, said the UK-based university. The method can be used to differentiate the SARS-CoV-2 virus from negative clinical samples and also from other common respiratory pathogens […]

Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate

Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine development company is carrying out the late-stage trial in the UK in partnership with the UK government’s Vaccines Taskforce. The phase 3 trial of NVX-CoV2373 will aim to enroll and […]

Continue reading …
Bayer to acquire KaNDy Therapeutics to add menopause drug candidate

Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to $900 million, in a move to grow its drug development pipeline in women’s healthcare. Through the acquisition, the German healthcare company gains access to NT-814, a non-hormonal, once-daily, oral neurokinin-1,3 receptor antagonist in developmen for the treatment […]

Continue reading …
Olympus Corporation to acquire Arc Medical Design from Norgine

Olympus Corporation, a Japanese optical products company, has agreed to acquire Arc Medical Design, a UK-based subsidiary of Dutch specialist pharma company Norgine for an undisclosed price. The Japanese firm said that the acquisition helps it expand its offering in gastrointestinal therapeutic devices. Besides, the transaction will help Olympus Corporation in its development of advanced […]

Continue reading …
Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK

Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed COVID-19 vaccine candidate. The agreement will be subject to a final contract issued by the British government. The COVID-19 vaccine candidate has been developed by Sanofi in partnership with British […]

Continue reading …
COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine (AZD1222) to be well tolerated besides generating strong responses in all evaluated participants against the COVID-19 causing SARS-CoV-2 virus. The early-stage COVID-19 vaccine trial is being led by Oxford University, […]

Continue reading …
Topcon Healthcare acquires Henson perimeter business of Elektron Eye Technology

Topcon Healthcare, a US ophthalmic device manufacturer, has acquired the Henson perimeter business of UK-based Elektron Eye Technology (EET) for an undisclosed price. The range of perimetry products acquired includes the Henson 9000 and Henson 7000 perimetry screening devices along with the transfer of a number of Elektron Eye Technology employees to the US company. […]

Continue reading …
Imperial College begins human trial of coronavirus vaccine candidate COVAC1

Imperial College London said that it has dosed the first healthy volunteer with its COVAC1 coronavirus vaccine candidate, which has been developed using the new self-amplifying RNA (saRNA) technology. The university claimed that the COVID-19 vaccine candidate has gone through rigorous pre-clinical safety tests, and in animal studies, it has been demonstrated to be safe, […]

Continue reading …
Dexamethasone improves survival of COVID-19 patients in RECOVERY trial

The University of Oxford said that steroid dexamethasone has succeeded in reducing death in the ongoing RECOVERY trial in hospitalized patients with severe respiratory complications of COVID-19. The RECOVERY trial was launched in March 2020 as a randomized clinical trial to evaluate a range of potential treatments for coronavirus, including low-dose dexamethasone, which is a steroid […]

Continue reading …
AI drug discovery company Exscientia raises $60m in Series C round

Exscientia, a UK-based artificial intelligence (AI) drug discovery company, has secured $60 million in a Series C financing round led by new investor Novo Holdings, a Danish firm, which is fully owned by the Novo Nordisk Foundation. Existing investors – Evotec, Bristol Myers Squibb, and GT Healthcare Capital also took part in the funding round […]

Continue reading …
Page 1 of 3123